Is it recommended to administer the influenza vaccine in the buttocks?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Influenza Vaccine Administration Site: Avoid the Buttocks

The influenza vaccine should not be administered in the buttocks as this site is not recommended by the Advisory Committee on Immunization Practices (ACIP). 1

Proper Administration Sites for Influenza Vaccines

For Adults and Older Children:

  • Recommended site: Deltoid muscle 1, 2
  • Needle length: >1 inch (25mm) for most adults to ensure proper penetration into muscle tissue 2
  • Volume: 0.5 mL for persons ≥3 years (36 months) 1

For Infants and Young Children:

  • Recommended site: Anterolateral aspect of the thigh 1
  • Needle length: 7/8-1 inch (22-25mm) for children <12 months 2
  • Volume: 0.25 mL for infants and toddlers 6-35 months of age 1

Why the Buttocks Should Be Avoided

Administering influenza vaccine in the buttocks is problematic for several reasons:

  1. Reduced immunogenicity: Injection into gluteal fat rather than muscle can lead to suboptimal immune response
  2. Risk of sciatic nerve injury: The gluteal area contains the sciatic nerve which could be injured during injection
  3. Inconsistent absorption: The buttocks often have more subcutaneous fat, leading to variable vaccine absorption

Special Considerations

  • Intradermal formulation: Some influenza vaccines (like Fluzone Intradermal Quadrivalent) are administered intradermally, preferably over the deltoid muscle, using a specialized delivery system 1
  • Jet injector administration: Certain IIVs (Afluria and Afluria Quadrivalent) are licensed for intramuscular administration via jet injector for persons aged 18-64 years 1
  • Body mass considerations: Healthcare providers should consider patient factors such as body mass index and subcutaneous tissue thickness when selecting needle length 2

Common Pitfalls to Avoid

  1. Splitting doses: A 0.5-mL unit dose of any IIV should never be split into two separate 0.25-mL doses due to safety concerns, including lack of sterility 1
  2. Inadequate needle length: Using needles that are too short (<1 inch) for adults may result in subcutaneous rather than intramuscular administration, potentially reducing vaccine effectiveness 2
  3. Using expired vaccines: Previous season's vaccines should not be used for the current influenza season 1

Following these evidence-based administration guidelines will help ensure optimal vaccine effectiveness and minimize adverse events.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Intramuscular Flu Vaccine Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.